Požymis
Psychosis
A condition characterized by changes in personality and thought patterns, often accompanied by hallucinations and delusional beliefs, is known as psychosis.
Santrauka
- Kūno sistema
- Abnormality of the nervous system
Read the genes linked to Psychosis, and the rest of your genome, with one test.
Nuo 449 $Nemokamas pristatymas · Rezultatai per 6–8 savaites
Įsigyti savo Genome Test147 genų susiję su Psychosis
Šių genų pakitimai sukelia retas ligas, kuriose pasireiškia Psychosis. Dauguma žmonių, turinčių šį požymį, neturi nė vienos iš tų ligų, o šiame sąraše esantis genas nieko nesako apie kieno nors paties genomą.
| Genas | Kaip dažnai pasireiškia | Ligos |
|---|---|---|
| LRRC7leucine rich repeat containing 7 | Visada | 1 ligoje |
| MMADHCmetabolism of cobalamin associated D | Visada | 1 ligoje |
| NOTCH3notch receptor 3 | Visada | 1 ligoje |
| RFC4replication factor C subunit 4 | Visada | 1 ligoje |
| TBC1D7TBC1 domain family member 7 | Visada | 1 ligoje |
| TRRAPtransformation/transcription domain associated protein | Visada | 1 ligoje |
| UNC13Aunc-13 homolog A | Visada | 1 ligoje |
| WFS1wolframin ER transmembrane glycoprotein | Labai dažnai (80–99%) | 1 ligoje |
| CMPK2cytidine/uridine monophosphate kinase 2 | Dažnai (30–79%) | 1 ligoje |
| DNMT1DNA methyltransferase 1 | Dažnai (30–79%) | 1 ligoje |
| H4C3H4 clustered histone 3 | Dažnai (30–79%) | 1 ligoje |
| JAM2junctional adhesion molecule 2 | Dažnai (30–79%) | 2 ligose |
| MAGEL2MAGE family member L2 | Dažnai (30–79%) | 5 ligose |
| MT-CO1mitochondrially encoded cytochrome c oxidase I | Dažnai (30–79%) | 1 ligoje |
| MT-CO2mitochondrially encoded cytochrome c oxidase II | Dažnai (30–79%) | 1 ligoje |
| MT-CO3mitochondrially encoded cytochrome c oxidase III | Dažnai (30–79%) | 1 ligoje |
| MT-ND1mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 1 | Dažnai (30–79%) | 1 ligoje |
| MT-ND4mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 4 | Dažnai (30–79%) | 1 ligoje |
| MT-ND5mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 5 | Dažnai (30–79%) | 1 ligoje |
| MT-ND6mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 6 | Dažnai (30–79%) | 1 ligoje |
| MT-TFmitochondrially encoded tRNA-Phe (UUU/C) | Dažnai (30–79%) | 1 ligoje |
| MT-THmitochondrially encoded tRNA-His (CAU/C) | Dažnai (30–79%) | 1 ligoje |
| MT-TL1mitochondrially encoded tRNA-Leu (UUA/G) 1 | Dažnai (30–79%) | 1 ligoje |
| MT-TQmitochondrially encoded tRNA-Gln (CAA/G) | Dažnai (30–79%) | 1 ligoje |
| MT-TS1mitochondrially encoded tRNA-Ser (UCN) 1 | Dažnai (30–79%) | 1 ligoje |
| MT-TS2mitochondrially encoded tRNA-Ser (AGU/C) 2 | Dažnai (30–79%) | 1 ligoje |
| MT-TWmitochondrially encoded tRNA-Trp (UGA/G) | Dažnai (30–79%) | 1 ligoje |
| MYORGmyogenesis regulating glycosidase | Dažnai (30–79%) | 3 ligose |
| NAA60N-alpha-acetyltransferase 60, NatF catalytic subunit | Dažnai (30–79%) | 3 ligose |
| NDNnecdin, MAGE family member | Dažnai (30–79%) | 3 ligose |
| NDPnorrin cystine knot growth factor NDP | Dažnai (30–79%) | 2 ligose |
| OCA2OCA2 melanosomal transmembrane protein | Dažnai (30–79%) | 3 ligose |
| PDGFBplatelet derived growth factor subunit B | Dažnai (30–79%) | 3 ligose |
| PDGFRBplatelet derived growth factor receptor beta | Dažnai (30–79%) | 2 ligose |
| RRP12ribosomal RNA processing 12 homolog | Dažnai (30–79%) | 1 ligoje |
| SLC20A2solute carrier family 20 member 2 | Dažnai (30–79%) | 2 ligose |
| SNRPNsmall nuclear ribonucleoprotein polypeptide N | Dažnai (30–79%) | 3 ligose |
| TPM2tropomyosin 2 | Dažnai (30–79%) | 1 ligoje |
| WARS2tryptophanyl tRNA synthetase 2, mitochondrial | Dažnai (30–79%) | 1 ligoje |
| XPR1xenotropic and polytropic retrovirus receptor 1 | Dažnai (30–79%) | 2 ligose |
Rodyti dar 107 genų
| Genas | Kaip dažnai pasireiškia | Ligos |
|---|---|---|
| AARS2alanyl-tRNA synthetase 2, mitochondrial | Kartais (5–29%) | 1 ligoje |
| ACADSacyl-CoA dehydrogenase short chain | Kartais (5–29%) | 1 ligoje |
| ALDH18A1aldehyde dehydrogenase 18 family member A1 | Kartais (5–29%) | 1 ligoje |
| ASLargininosuccinate lyase | Kartais (5–29%) | 1 ligoje |
| ATP7BATPase copper transporting beta | Kartais (5–29%) | 1 ligoje |
| ATXN7ataxin 7 | Kartais (5–29%) | 1 ligoje |
| BRD4bromodomain containing 4 | Kartais (5–29%) | 1 ligoje |
| CACNA1Acalcium voltage-gated channel subunit alpha1 A | Kartais (5–29%) | 2 ligose |
| CBScystathionine beta-synthase | Kartais (5–29%) | 1 ligoje |
| CHD2chromodomain helicase DNA binding protein 2 | Kartais (5–29%) | 1 ligoje |
| CHD8chromodomain helicase DNA binding protein 8 | Kartais (5–29%) | 1 ligoje |
| CHMP2Bcharged multivesicular body protein 2B | Kartais (5–29%) | 1 ligoje |
| CLTRNcollectrin, amino acid transport regulator | Kartais (5–29%) | 1 ligoje |
| CPOXcoproporphyrinogen oxidase | Kartais (5–29%) | 1 ligoje |
| CUX2cut like homeobox 2 | Kartais (5–29%) | 1 ligoje |
| DCAF17DDB1 and CUL4 associated factor 17 | Kartais (5–29%) | 2 ligose |
| DNM1dynamin 1 | Kartais (5–29%) | 1 ligoje |
| EHMT1euchromatic histone lysine methyltransferase 1 | Kartais (5–29%) | 1 ligoje |
| GABRB3gamma-aminobutyric acid type A receptor subunit beta3 | Kartais (5–29%) | 1 ligoje |
| GCLCglutamate-cysteine ligase catalytic subunit | Kartais (5–29%) | 1 ligoje |
| GRNgranulin precursor | Kartais (5–29%) | 1 ligoje |
| HERC2HECT and RLD domain containing E3 ubiquitin protein ligase 2 | Kartais (5–29%) | 1 ligoje |
| IRAK1interleukin 1 receptor associated kinase 1 | Kartais (5–29%) | 1 ligoje |
| JARID2jumonji and AT-rich interaction domain containing 2 | Kartais (5–29%) | 1 ligoje |
| KCNN2potassium calcium-activated channel subfamily N member 2 | Kartais (5–29%) | 1 ligoje |
| KCNT1potassium sodium-activated channel subfamily T member 1 | Kartais (5–29%) | 1 ligoje |
| KDM6Blysine demethylase 6B | Kartais (5–29%) | 1 ligoje |
| MAPK10mitogen-activated protein kinase 10 | Kartais (5–29%) | 1 ligoje |
| MAPTmicrotubule associated protein tau | Kartais (5–29%) | 1 ligoje |
| MECP2methyl-CpG binding protein 2 | Kartais (5–29%) | 1 ligoje |
| MED12mediator complex subunit 12 | Kartais (5–29%) | 2 ligose |
| MKRN3makorin ring finger protein 3 | Kartais (5–29%) | 1 ligoje |
| MTHFRmethylenetetrahydrofolate reductase | Kartais (5–29%) | 1 ligoje |
| NIT1nitrilase 1 | Kartais (5–29%) | 1 ligoje |
| NPAP1nuclear pore associated protein 1 | Kartais (5–29%) | 1 ligoje |
| PAK3p21 (RAC1) activated kinase 3 | Kartais (5–29%) | 1 ligoje |
| PIDD1p53-induced death domain protein 1 | Kartais (5–29%) | 1 ligoje |
| PRORPprotein only RNase P catalytic subunit | Kartais (5–29%) | 1 ligoje |
| PSEN1presenilin 1 | Kartais (5–29%) | 1 ligoje |
| PUS3pseudouridine synthase 3 | Kartais (5–29%) | 1 ligoje |
| PWAR1Prader Willi/Angelman region RNA 1 | Kartais (5–29%) | 1 ligoje |
| PWRN1Prader-Willi region non-protein coding RNA 1 | Kartais (5–29%) | 1 ligoje |
| RPS6KA3ribosomal protein S6 kinase A3 | Kartais (5–29%) | 1 ligoje |
| SAT1spermidine/spermine N1-acetyltransferase 1 | Kartais (5–29%) | 1 ligoje |
| SCN1Asodium voltage-gated channel alpha subunit 1 | Kartais (5–29%) | 1 ligoje |
| SIM1SIM bHLH transcription factor 1 | Kartais (5–29%) | 1 ligoje |
| SLC25A13solute carrier family 25 member 13 | Kartais (5–29%) | 1 ligoje |
| SLC6A19solute carrier family 6 member 19 | Kartais (5–29%) | 2 ligose |
| SMAD4SMAD family member 4 | Kartais (5–29%) | 1 ligoje |
| SNORD115-1small nucleolar RNA, C/D box 115-1 | Kartais (5–29%) | 1 ligoje |
| SNORD116-1small nucleolar RNA, C/D box 116-1 | Kartais (5–29%) | 1 ligoje |
| SOBPsine oculis binding protein homolog | Kartais (5–29%) | 1 ligoje |
| SPARTspartin | Kartais (5–29%) | 1 ligoje |
| SPG11SPG11 vesicle trafficking associated, spatacsin | Kartais (5–29%) | 1 ligoje |
| SPP1secreted phosphoprotein 1 | Kartais (5–29%) | 1 ligoje |
| SQSTM1sequestosome 1 | Kartais (5–29%) | 1 ligoje |
| SRCAPSnf2 related CREBBP activator protein | Kartais (5–29%) | 1 ligoje |
| STAT4signal transducer and activator of transcription 4 | Kartais (5–29%) | 1 ligoje |
| TMEM106Btransmembrane protein 106B | Kartais (5–29%) | 2 ligose |
| TREM2triggering receptor expressed on myeloid cells 2 | Kartais (5–29%) | 1 ligoje |
| TREX1three prime repair exonuclease 1 | Kartais (5–29%) | 2 ligose |
| UPF3BUPF3B regulator of nonsense mediated mRNA decay | Kartais (5–29%) | 1 ligoje |
| VCPvalosin containing protein | Kartais (5–29%) | 1 ligoje |
| ZDHHC9zDHHC palmitoyltransferase 9 | Kartais (5–29%) | 1 ligoje |
| ZMYM2zinc finger MYM-type containing 2 | Kartais (5–29%) | 1 ligoje |
| ATRXATRX chromatin remodeler | Retai (1–4 %) | 1 ligoje |
| BRAFB-Raf proto-oncogene, serine/threonine kinase | Retai (1–4 %) | 1 ligoje |
| CDH23cadherin related 23 | Retai (1–4 %) | 1 ligoje |
| CTSHcathepsin H | Retai (1–4 %) | 1 ligoje |
| EIF3Feukaryotic translation initiation factor 3 subunit F | Retai (1–4 %) | 1 ligoje |
| FTLferritin light chain | Retai (1–4 %) | 1 ligoje |
| HCRThypocretin neuropeptide precursor | Retai (1–4 %) | 1 ligoje |
| HLA-DQB1major histocompatibility complex, class II, DQ beta 1 | Retai (1–4 %) | 1 ligoje |
| HLA-DRB1major histocompatibility complex, class II, DR beta 1 | Retai (1–4 %) | 1 ligoje |
| MMACHCmetabolism of cobalamin associated C | Retai (1–4 %) | 1 ligoje |
| MOGmyelin oligodendrocyte glycoprotein | Retai (1–4 %) | 1 ligoje |
| NR3C1nuclear receptor subfamily 3 group C member 1 | Retai (1–4 %) | 1 ligoje |
| P2RY11purinergic receptor P2Y11 | Retai (1–4 %) | 1 ligoje |
| PANK2pantothenate kinase 2 | Retai (1–4 %) | 1 ligoje |
| PCDH19protocadherin 19 | Retai (1–4 %) | 2 ligose |
| TNFSF4TNF superfamily member 4 | Retai (1–4 %) | 1 ligoje |
| TP53tumor protein p53 | Retai (1–4 %) | 1 ligoje |
| USP48ubiquitin specific peptidase 48 | Retai (1–4 %) | 1 ligoje |
| USP8ubiquitin specific peptidase 8 | Retai (1–4 %) | 1 ligoje |
| ZNF365zinc finger protein 365 | Retai (1–4 %) | 1 ligoje |
| ABCD1ATP binding cassette subfamily D member 1 | Neužfiksuota | 1 ligoje |
| ALDH5A1aldehyde dehydrogenase 5 family member A1 | Neužfiksuota | 1 ligoje |
| CLN3CLN3 lysosomal/endosomal transmembrane protein, battenin | Neužfiksuota | 1 ligoje |
| DNASE1deoxyribonuclease 1 | Neužfiksuota | 1 ligoje |
| EPM2AEPM2A glucan phosphatase, laforin | Neužfiksuota | 1 ligoje |
| FCGR2AFc gamma receptor IIa | Neužfiksuota | 1 ligoje |
| FCGR2BFc gamma receptor IIb | Neužfiksuota | 1 ligoje |
| GNASGNAS complex locus | Neužfiksuota | 1 ligoje |
| ITM2Bintegral membrane protein 2B | Neužfiksuota | 1 ligoje |
| NPC1NPC intracellular cholesterol transporter 1 | Neužfiksuota | 1 ligoje |
| NPC2NPC intracellular cholesterol transporter 2 | Neužfiksuota | 1 ligoje |
| PAHphenylalanine hydroxylase | Neužfiksuota | 1 ligoje |
| PDE11Aphosphodiesterase 11A | Neužfiksuota | 1 ligoje |
| PPOXprotoporphyrinogen oxidase | Neužfiksuota | 1 ligoje |
| PRDM8PR/SET domain 8 | Neužfiksuota | 1 ligoje |
| PRKAR1Aprotein kinase cAMP-dependent type I regulatory subunit alpha | Neužfiksuota | 1 ligoje |
| PRNPprion protein (Kanno blood group) | Neužfiksuota | 1 ligoje |
| SLC12A6solute carrier family 12 member 6 | Neužfiksuota | 1 ligoje |
| TTC19tetratricopeptide repeat domain 19 | Neužfiksuota | 1 ligoje |
| TWNKtwinkle mtDNA helicase | Neužfiksuota | 1 ligoje |
| VPS13Avacuolar protein sorting 13 homolog A | Neužfiksuota | 1 ligoje |
| ZFYVE26zinc finger FYVE-type containing 26 | Neužfiksuota | 1 ligoje |
Kaip dažnai šis požymis pasitaiko žmonėms, turintiems vieną iš geno sukeliamų ligų, ir kuris dažnis tarp jų didžiausias, pagal Žmogaus fenotipo ontologijos duomenis. Šiuose puslapiuose aprašomi požymiai ir juos grindžiantys tyrimai; tai nėra diagnozė, o su simptomais kreipkitės į gydytoją ar genetikos konsultantą.
Platesni požymiai
Iš kur tai žinoma
- Žmogaus fenotipo ontologija, 2026-09-01 leidimas: požymis, jo pavadinimai, apibrėžimas ir su juo susiję genai. Daugiau sužinokite svetainėje hpo.jax.org.
- Duomenų leidimas 2026.10.16-c6eea6bf.
Vienas testas. Atsakymai visam gyvenimui.
Nuo 449 $Nemokamas pristatymas · Rezultatai per 6–8 savaites